These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38193308)

  • 1. Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives.
    Dobre MA; Ahlawat S; Schelling JR
    Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):203-211. PubMed ID: 38193308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.
    Law JP; Pickup L; Pavlovic D; Townend JN; Ferro CJ
    J Hum Hypertens; 2023 Jan; 37(1):1-19. PubMed ID: 36138105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
    Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
    Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the kisspeptin-KISS1R axis in the pathogenesis of chronic kidney disease and uremic cardiomyopathy.
    Dinh H; Kovács ZZA; Kis M; Kupecz K; Sejben A; Szűcs G; Márványkövi F; Siska A; Freiwan M; Pósa SP; Galla Z; Ibos KE; Bodnár É; Lauber GY; Goncalves AIA; Acar E; Kriston A; Kovács F; Horváth P; Bozsó Z; Tóth G; Földesi I; Monostori P; Cserni G; Podesser BK; Lehoczki A; Pokreisz P; Kiss A; Dux L; Csabafi K; Sárközy M
    Geroscience; 2024 Apr; 46(2):2463-2488. PubMed ID: 37987885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Involvement in Patients with Chronic Kidney Disease.
    Bhattacharya A; Rana K; Vanpariya N; Roy R; Radadiya T; Singh S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomic analysis of rat left ventricle in a subtotal nephrectomy model.
    Lin YP; Yu WC; Hsu ME; Tsai HC; Liao CC; Lin CH
    J Chin Med Assoc; 2015 Apr; 78(4):218-28. PubMed ID: 25537970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
    Dellegrottaglie S; Sands RL; Gillespie BW; Gnanasekaran G; Zannad F; Sengstock D; Finkelstein F; Kiser M; Eisele G; Hinderliter AL; Levin NW; Cattan V; Saran R; Rajagopalan S
    Nephrol Dial Transplant; 2011 Sep; 26(9):2891-8. PubMed ID: 21562144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.
    Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
    Bartnicki P; Kowalczyk M; Franczyk-Skóra B; Baj Z; Rysz J
    Curr Vasc Pharmacol; 2016; 14(4):360-7. PubMed ID: 26759218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume.
    Kadappu KK; Abhayaratna K; Boyd A; French JK; Xuan W; Abhayaratna W; Thomas L
    J Am Soc Echocardiogr; 2016 Apr; 29(4):359-67. PubMed ID: 26743735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance.
    Edwards NC; Moody WE; Chue CD; Ferro CJ; Townend JN; Steeds RP
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):703-14. PubMed ID: 25034920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
    Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
    Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H
    Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease.
    Hayer MK; Price AM; Liu B; Baig S; Ferro CJ; Townend JN; Steeds RP; Edwards NC
    Am J Cardiol; 2018 Mar; 121(5):656-660. PubMed ID: 29366457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
    Chinnappa S; Hothi SS; Tan LB
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac biomarkers in pediatric CKD-a prospective follow-up study.
    Lindblad YT; Vavilis G; Chromek M; Quershi AR; Löwbeer C; Bárány P
    Pediatr Nephrol; 2022 Dec; 37(12):3165-3175. PubMed ID: 35294668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review.
    Mentz RJ; Brunton SA; Rangaswami J
    Cardiovasc Diabetol; 2023 Nov; 22(1):316. PubMed ID: 37974185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients.
    Romejko K; Rymarz A; Szamotulska K; Bartoszewicz Z; Niemczyk S
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.